These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 16043677

  • 1. Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.
    Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA.
    Arch Intern Med; 2005 Jul 25; 165(14):1600-5. PubMed ID: 16043677
    [Abstract] [Full Text] [Related]

  • 2. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
    Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ.
    Arch Gen Psychiatry; 2004 Sep 25; 61(9):905-12. PubMed ID: 15351769
    [Abstract] [Full Text] [Related]

  • 3. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
    Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ.
    Lancet; 2003 May 17; 361(9370):1677-85. PubMed ID: 12767733
    [Abstract] [Full Text] [Related]

  • 4. Topiramate reduces the harm of excessive drinking: implications for public health and primary care.
    Ma JZ, Ait-Daoud N, Johnson BA.
    Addiction; 2006 Nov 17; 101(11):1561-8. PubMed ID: 17034435
    [Abstract] [Full Text] [Related]

  • 5. Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.
    Anthenelli RM, Blom TJ, McElroy SL, Keck PE.
    Addiction; 2008 Apr 17; 103(4):687-94. PubMed ID: 18339115
    [Abstract] [Full Text] [Related]

  • 6. A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol-Dependent Men.
    Anthenelli RM, Heffner JL, Wong E, Tibbs J, Russell K, Isgro M, Dinh E, Wehrle C, Worley MJ, Doran N.
    Alcohol Clin Exp Res; 2017 Jan 17; 41(1):197-206. PubMed ID: 28029173
    [Abstract] [Full Text] [Related]

  • 7. Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients.
    Baltieri DA, Daró FR, Ribeiro PL, Andrade AG.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):33-41. PubMed ID: 19595518
    [Abstract] [Full Text] [Related]

  • 8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group.
    Cephalalgia; 2007 Jul 01; 27(7):814-23. PubMed ID: 17441971
    [Abstract] [Full Text] [Related]

  • 9. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care.
    Fossati R, Apolone G, Negri E, Compagnoni A, La Vecchia C, Mangano S, Clivio L, Garattini S, General Practice Tobacco Cessation Investigators Group.
    Arch Intern Med; 2007 Sep 10; 167(16):1791-7. PubMed ID: 17846399
    [Abstract] [Full Text] [Related]

  • 10. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
    Likhitsathian S, Uttawichai K, Booncharoen H, Wittayanookulluk A, Angkurawaranon C, Srisurapanont M.
    Drug Alcohol Depend; 2013 Dec 01; 133(2):440-6. PubMed ID: 23906999
    [Abstract] [Full Text] [Related]

  • 11. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.
    Isgro M, Doran N, Heffner JL, Wong E, Dinh E, Tibbs J, Russell K, Bittner T, Wehrle C, Worley MJ, Anthenelli RM.
    J Stud Alcohol Drugs; 2017 Mar 01; 78(2):232-240. PubMed ID: 28317503
    [Abstract] [Full Text] [Related]

  • 12. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL, Jones L, Lancaster T, Fowler GH.
    Br J Gen Pract; 1996 Mar 01; 46(404):145-8. PubMed ID: 8731618
    [Abstract] [Full Text] [Related]

  • 13. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial.
    Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, Topiramate for Alcoholism Advisory Board, Topiramate for Alcoholism Study Group.
    Arch Intern Med; 2008 Jun 09; 168(11):1188-99. PubMed ID: 18541827
    [Abstract] [Full Text] [Related]

  • 14. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug 09; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 15. A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
    O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.
    Arch Intern Med; 2006 Mar 27; 166(6):667-74. PubMed ID: 16567607
    [Abstract] [Full Text] [Related]

  • 16. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG, Gitchell JG, Shiffman S, Sembower MA.
    Clin Ther; 2009 Sep 27; 31(9):1957-65. PubMed ID: 19843485
    [Abstract] [Full Text] [Related]

  • 17. Topiramate for treating alcohol dependence: a randomized controlled trial.
    Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, Topiramate for Alcoholism Advisory Board, Topiramate for Alcoholism Study Group.
    JAMA; 2007 Oct 10; 298(14):1641-51. PubMed ID: 17925516
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
    Baldaçara L, Cogo-Moreira H, Parreira BL, Diniz TA, Milhomem JJ, Fernandes CC, Lacerda AL.
    J Clin Psychiatry; 2016 Mar 10; 77(3):398-406. PubMed ID: 27046312
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J, Topiramate Chronic Migraine Study Group.
    Headache; 2007 Feb 10; 47(2):170-80. PubMed ID: 17300356
    [Abstract] [Full Text] [Related]

  • 20. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
    Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, CAPSS-141 Study Group.
    Clin Ther; 2005 Sep 10; 27(9):1420-31. PubMed ID: 16291415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.